Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors
Clinical trial NCT03700294 · TERMINATED
Trial details
- NCT number
- NCT03700294
- Sponsor
- ADC Therapeutics S.A.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-21
- Primary completion
- 2019-12-11
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.